Related Experiment Video

Updated: Sep 7, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Strategies for the prenatal diagnosis of primary hyperoxaluria type 1

C J Danpure1, G Rumsby

  • 1MRC Laboratory for Molecular Cell Biology, University College London, UK.

Prenatal Diagnosis
|July 1, 1996
PubMed

Insights

Prenatal diagnosis of Primary Hyperoxaluria type 1 (PH1) has advanced using DNA analysis and fetal liver biopsies. These methods offer effective early detection for this serious genetic disorder.

Area of Science:

  • Medical Genetics
  • Metabolic Disorders
  • Peroxisomal Biology

Background:

  • Primary Hyperoxaluria type 1 (PH1) is a severe, inherited metabolic disorder.
  • It results from a deficiency in the enzyme alanine:glyoxylate aminotransferase (AGT).
  • PH1 leads to kidney stone formation and potential organ failure.

Purpose of the Study:

  • To review and discuss methodologies for the prenatal diagnosis of PH1.
  • To evaluate the evolution and effectiveness of diagnostic strategies.
  • To provide examples and compare the pros and cons of different prenatal testing approaches.

Main Methods:

  • Analysis of amniotic fluid metabolites (second trimester).
  • Fetal liver biopsy for AGT enzyme assay, immunoassay, and immuno-electron microscopy (second trimester).
  • DNA-based linkage and mutation analysis from chorionic villus samples (first trimester).

Main Results:

  • First-trimester DNA analysis and second-trimester fetal liver biopsy methods have proven successful for PH1 prenatal diagnosis.
  • Metabolite analysis of amniotic fluid has shown limited proven utility.
  • Diagnostic techniques have improved with better understanding of PH1's molecular basis.

Conclusions:

  • Prenatal diagnosis of PH1 is achievable through various advanced techniques.
  • DNA analysis and fetal liver biopsy are reliable methods for early detection.
  • Continued research refines diagnostic accuracy for this genetic condition.

More Related Videos

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring07:35

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring

Published on: June 23, 2015

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis07:45

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

Published on: February 9, 2021

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...